Teleflex Inc (TFX)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$120.08

Buy

$135.95

arrow-down$-0.37 (-0.29%)

Prices updated at 12 Dec 2025, 21:36 EST

Prices minimum 15 mins delay

Prices in USD

Teleflex Inc designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Liam J. Kelly

CEO

Mr. Liam J. Kelly

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

14,100

Head office

550 East Swedesford Road

Wayne

United States

19087

+1 610 225-6800

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. John R. Deren Executive Vice President and Chief Financial Officer	-
Ms. Gretchen R. Haggerty Independent Director	0.09m
Mr. John C. Heinmiller Independent Director	0.09m
Dr. Stephen K. Klasko Lead Independent Director	0.10m
Mr. Stuart A. Randle Independent Director	0.11m
Mr. Andrew A. Krakauer Independent Director	0.09m
Mr. Liam J. Kelly Chairman of the Board, President and Chief Executive Officer	1.11m
Mr. Cameron P. Hicks Corporate Vice President, Human Resources and Communications	-
Ms. Candace H. Duncan Independent Director	0.11m
Ms. Neena M. Patil Independent Director	0.08m
Mr. James P. Winters Corporate Vice President, Manufacturing and Supply Chain	0.43m
Mr. Daniel V. Logue Corporate Vice President, General Counsel and Secretary	0.44m
Mr. Jay K. White Corporate Vice President and President, Global Commercial	0.63m
Dr. Jaewon Ryu, J.D.,M.D. Independent Director	0.09m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Janus Capital Management LLC	5,771,740
BlackRock Inc	5,337,323
Janus Henderson Group PLC	5,376,452
Vanguard Group Inc	4,813,781
T. Rowe Price Investment Management,Inc.	4,569,043

Director dealings

Date chevron-l-regular chevron-r-regular	Action
24 Aug 2024	-
16 Aug 2024	-
16 Aug 2024	-
16 Aug 2024	-
18 Jun 2024	-
18 Jun 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.